Science

Liquid Biopsy Response Evaluation Criteria in Solid Tumor – International Society of Liquid Biopsy

Mohamed Alaa Gouda/researchgate.net

Dec 19, 2024, 21:11

Liquid Biopsy Response Evaluation Criteria in Solid Tumor – International Society of Liquid Biopsy

International Society of Liquid Biopsy shared a recent article by Mohamed Alaa Gouda on X:

“Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) .

Key Highlights:

ctDNA dynamics can predict treatment response earlier than imaging.
Proposed LB-RECIST criteria aim to standardize ctDNA-based response assessment.
A step forward for precision oncology and real-time monitoring.

Title: Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)

Authors: Mohamed Alaa Gouda, F. Janku, A. Wahida, L. Buschhorn, A. Schneeweiss, N. Abdel Karim, D. De Miguel Perez, M. Del Re, A. Russo, G. Curigliano, C. Rolfo and V. Subbiah

Liquid Biopsy

More posts featuring International Society of Liquid Biopsy.

A. Schneeweiss A. Wahida biopsy C. Rolfo cancer F. Janku International Society of Liquid Biopsy L. Buschhorn liquid biopsy M.A. Gouda OncoDaily Oncology solid tumors tumors V Subbiah

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage